This unique international conference provides a platform for researchers and decision makers in biotechnology to present their latest findings and learn about all the important developments in biotechnology. Four Nobel Laureates and many world renowned experts will participate at the conference.

The conference will cover the translational nature of biotechnological research, with emphasis on both the basic science as well as its applications in industry and academia. Presentations will include latest researches, business development, strategic alliances, partnering trends, product opportunities, growth business models and strategies, licensing and pharmaceutical biotechnology (e.g. vaccines, CNS, cancer, antibodies), medical biotechnology, industrial biotechnology, bioprocess engineering, protein engineering, plant and environmental technologies, transgenic plant and crops, bioremediation, and microbial diversity research.

Throughout the course of the two day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate biotechnology communities.

The conference is organized by Eureka Science with the support of the Higher Colleges of Technology, UAE, and it focuses on the interdisciplinary fields of biotechnology.

http://www.biotechworldcongress.com/

The goal of the Keystone Symposia meeting on Non-Coding RNAs is to highlight the similarities and differences in various model systems to better understand the role of long ncRNAs in the regulation of genomes. This is an entirely new emerging field of study that is on the forefront of modern biology. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Eukaryotic Transcription, which will share a plenary session with this meeting.

http://www.keystonesymposia.org/12Z1

Biomarker has become a buzz word in both the pharmaceuticals and diagnostics sectors within the last few years, with promising results in pharmacogenomics studies and molecular diagnostics; and especially in the field of drug-diagnostic co-development where it’s potential in companion diagnostics have been fuelling the ultimate promise of a future towards personalised healthcare.

2nd Annual BDT2012 endeavours to grow the discussion further by congregating the insights of leaders from the diagnostics, pharmaceuticals, medical and academic fields to evaluate developments that have materialised from the promise of biomarker R&D. We will review progresses in areas of companion diagnostics, clinical drug development and in personalising treatment options with a reality check on translating biomarker studies into clinical practice. Key hurdles in biomarker identification and validation will be handled, while technological solutions, new research targets and discovery strategies aiding in the translation of biomarker towards bedside applications will be critically examined.

http://www.eventprotocol.com/bdt2012.php

This Keystone Symposia conference will bring together world-leading researchers in the burgeoning field of proteomics, which is the large-scale study of the expressed proteins in biological systems. In comparison to genomics, proteomics has historically been limited by the available technology. However, this has now changed as the field has matured considerably over the last few years. Indeed, the proteomics field is at a critical junction, where very powerful technologies are now at our disposal. However, often the creativity evident within the proteomics disciplines does not extend to the creation of strategies that combine different approaches to study cellular phenomena. For instance, structural biologists use electron tomography of the entire cell and combine this with mass spectrometry to obtain a view of protein complexes or “machineries” that could not be achieved by each field working in isolation. The meeting will be unique in bringing together researchers from a diverse set of backgrounds that have now begun to transcend the boundaries of single-technology approaches.

This conference will address how to make best biological, biotechnology and clinical use of the tremendous opportunities that these technologies now provide. The speakers will lay out the achievements and the challenges of each field and illustrate the power of proteomics with specific cell biological or clinical applications. Importantly, many of the speakers will outline how they have begun to combine fundamentally different proteomics technologies to address biological questions. Participants can then together discuss and devise novel proteomic approaches to many biological and clinical questions.

http://www.keystonesymposia.org/12F2

The Human Genetics Society of Australasia is proud to invite you to attend the 36th Annual Scientific Meeting in Canberra, Australia from Sunday 22 to Wednesday 25 July 2012.

This meeting will have broad appeal for all scientists, clinicians and allied health professionals with an interest in human genetics. The meeting will be accredited for CPD points with the appropriate organisations.

http://www.hgsaconference.com.au/

The goal of the proposed Gordon Research Conference on Notch signaling in development, regeneration and disease is to provide a stimulating, international and cross disciplinary forum for the dissemination and discussion of new research, concepts and therapeutic opportunities at the forefront of Notch related biology.
The meeting will bring together a diverse community of scientists working in every model organism and on nearly every organ system from academia, biotech and the pharmaceutical industry. We aim to create a forum in which cutting edge technologies, ideas and discoveries can be exchanged. Most importantly, we aim to integrate students and postdocs in this academically intense and free environment into the study of Notch signaling.

http://www.grc.org/programs.aspx?year=2012&program=notchsig

For forthcoming announcements about the 24th EORTC-NCI-AACR Symposium please visit the website  www.ecco-org.eu, or contact the Congress Secretariat directly:

C/O  ECCO – the European CanCer Organisation
Avenue E. Mounier, 83
B-1200 Brussels
Belgium
Tel:  +32 2 775 02 01
Fax: +32 2 775 02 00
E-Mail: ena2012@ecco-org.eu

http://www.ecco-org.eu/Conferences-and-Events/EORTC-NCI-AACR-2012/page.aspx/2678